Investments, Funding & Disinvestment

The new collaboration centres on CSPC’s small interfering RNA (siRNA) drug discovery platform and its proprietary delivery technology, which is designed to transport therapies beyond the liver.

Following the sale, Clarivate will concentrate on its Academia & Government (A&G) and Intellectual Property (IP) divisions.

The financing round was co-led by M Ventures, the venture capital arm of Merck KGaA, and GordonMD Global Investments.

Following completion of the transaction, the business will operate under the new name Medswana Laborex and become part of CFAO Healthcare’s pan-African network.

The new Strengthening Public Health Surveillance and Resilient Knowledge for Non-Communicable Diseases in Africa (SPARK-NCD) programme aims to improve disease surveillance, workforce capacity, and integrated care across the continent.

Astex will also qualify for development, regulatory, and commercial milestone payments exceeding US$465 million, totaling US$490 million with the upfront payment included.

As part of the transaction, Besins Healthcare will take ownership of UniD Manufacturing’s production facility in Seraing, Belgium.

Founded in 2019 as a spinout from Imperial College London and the Francis Crick Institute, Myricx has attracted strong investor backing and has emerged as one of the UK’s leading oncology biotechnology companies.

Under the definitive agreement, which both companies’ boards unanimously approved, Vertex will pay US$85.00 in cash for each outstanding Crinetics share.

MedSahra connects medical equipment suppliers, healthcare providers, logistics companies, service providers, investors, technology firms, and business advisers through one platform.